Company / PP&E (Net)
Neurogene Inc. PP&E (Net) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$12.8M
FY2025
5-year range
$400.0K / $15.4M
FY2021-FY2025
Trend
-17.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $2M to $13M over the past 6 years.
Based on SEC 10-K filings.
$13M in FY2025.
Improved from $2M to $13M over the past 6 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, pp&e (net) decreased 17.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.24 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.8M | -17.1% |
| FY2024 | $15.4M | +648.6% |
| FY2019 | $2.1M | +415.0% |
| FY2018 | $400.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026